Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients with Esophageal Squamous Cell Cancer

Preclinical and clinical evidence suggests that the combination of radiotherapy with anti-PD-1 treatment can have a synergistic effect in the treatment of cancer. The objective of this study is to evaluate the efficacy and safety of radiation therapy combined with anti-PD-1 antibody SHR-1210 in patients with locally advanced esophageal squamous cell cancer (ESCC).